Literature DB >> 35167950

Ocular surface disease in thyroid eye disease: A narrative review.

Harkaran S Rana1, Sruti S Akella2, Carson E Clabeaux3, Zachary P Skurski4, Vinay K Aakalu5.   

Abstract

Ocular surface disease (OSD) in the setting of thyroid eye disease (TED) is traditionally thought of as a natural consequence of anatomical changes such as proptosis and corneal exposure. However, a growing body of research suggests that ocular surface inflammation and multi-factorial changes to the homeostasis of the ocular surface contribute substantially to the OSD seen in TED patients. In this paper we review the existing literature which highlights the work and existing theories underlying this new paradigm shift. Published by Elsevier Inc.

Entities:  

Keywords:  Dry eye; Exposure keratopathy; Ocular surface disease; Thyroid eye disease

Mesh:

Year:  2022        PMID: 35167950      PMCID: PMC9058200          DOI: 10.1016/j.jtos.2022.02.001

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   6.268


  78 in total

Review 1.  TFOS DEWS II Definition and Classification Report.

Authors:  Jennifer P Craig; Kelly K Nichols; Esen K Akpek; Barbara Caffery; Harminder S Dua; Choun-Ki Joo; Zuguo Liu; J Daniel Nelson; Jason J Nichols; Kazuo Tsubota; Fiona Stapleton
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

Review 2.  Cytokine assays: role in evaluation of the pathogenesis of autoimmunity.

Authors:  M Feldmann; F M Brennan; D Chantry; C Haworth; M Turner; P Katsikis; M Londei; E Abney; G Buchan; K Barrett
Journal:  Immunol Rev       Date:  1991-02       Impact factor: 12.988

3.  Tear film osmolarity: determination of a referent for dry eye diagnosis.

Authors:  Alan Tomlinson; Santosh Khanal; Kanna Ramaesh; Charles Diaper; Angus McFadyen
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-10       Impact factor: 4.799

4.  Dry eye in Graves ophthalmopathy: correlation with corneal hypoesthesia.

Authors:  Vasilis Achtsidis; Nicholas Tentolouris; Sofia Theodoropoulou; Dimitris Panagiotidis; Emmanuel Vaikoussis; Manuel Saldana; Pieter Gouws; Panagiotis G Theodossiadis
Journal:  Eur J Ophthalmol       Date:  2013-03-04       Impact factor: 2.597

5.  Observation of Corneal Langerhans Cells by In Vivo Confocal Microscopy in Thyroid-Associated Ophthalmopathy.

Authors:  Lian-Qun Wu; Jin-Wei Cheng; Ji-Ping Cai; Qi-Hua Le; Xiao-Ye Ma; Lian-Di Gao; Rui-Li Wei
Journal:  Curr Eye Res       Date:  2016-01-06       Impact factor: 2.424

6.  The levels of 12 cytokines and growth factors in tears: hyperthyreosis vs euthyreosis.

Authors:  Jelena Juri Mandić; Ana Kozmar; Sanja Kusačić-Kuna; Anamarija Jazbec; Krešimir Mandić; Danijela Mrazovac; Nenad Vukojević
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-14       Impact factor: 3.117

7.  Teprotumumab for the Treatment of Active Thyroid Eye Disease.

Authors:  Raymond S Douglas; George J Kahaly; Amy Patel; Saba Sile; Elizabeth H Z Thompson; Renee Perdok; James C Fleming; Brian T Fowler; Claudio Marcocci; Michele Marinò; Alessandro Antonelli; Roger Dailey; Gerald J Harris; Anja Eckstein; Jade Schiffman; Rosa Tang; Christine Nelson; Mario Salvi; Sara Wester; Jeffrey W Sherman; Thomas Vescio; Robert J Holt; Terry J Smith
Journal:  N Engl J Med       Date:  2020-01-23       Impact factor: 91.245

8.  Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes.

Authors:  F Willems; A Marchant; J P Delville; C Gérard; A Delvaux; T Velu; M de Boer; M Goldman
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

9.  Osmotic tolerance of human granulocytes.

Authors:  W J Armitage; P Mazur
Journal:  Am J Physiol       Date:  1984-11

10.  Dry eye syndrome in thyroid eye disease patients: The role of increased incomplete blinking and Meibomian gland loss.

Authors:  Jinhwan Park; Sehyun Baek
Journal:  Acta Ophthalmol       Date:  2018-12-28       Impact factor: 3.761

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.